IF

Ingro Finanz AG

Europe, Basel-Landschaft, Switzerland, Bubendorf

Description

Ingro Finanz AG is an investment holding company specialized in late stage venture investments.

Investor Profile

Ingro Finanz AG has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series C (50%)

Country Focus

  • Switzerland (50%)
  • Germany (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Medical
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ingro Finanz AG frequently co-invest with?

LI
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Varuma
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Landesbank Baden Wurttemberg
Europe, Baden-Wurttemberg, Germany, Stuttgart
Co-Investments: 1
Future Capital
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
BB
Europe, Solothurn, Switzerland, Wiler
Co-Investments: 1
Co-Investments: 1
Pictet Private Equity Investors S.A.
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1

What are some of recent deals done by Ingro Finanz AG?

NovImmune

Plan-les-ouates, Geneve, Switzerland

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.

BiotechnologyMedicalPharmaceutical
Series UnknownMay 12, 2009
Amount Raised: $54,800,000
Ganymed Pharmaceuticals

Mainz, Rheinland-Pfalz, Germany

Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.

BiopharmaBiotechnologyPharmaceutical
Series CSep 24, 2007
Amount Raised: $47,482,979